Structural and functional impact of the transgenic expression of cytokines in the CNS

Annals of the New York Academy of Sciences

Volumn 840, Issue , 1998, Pages 83-96

  Campbell, I L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; CELL DAMAGE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; ENCEPHALOMYELITIS; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION; MACROPHAGE; MEDIATOR; MICROGLIA; MOTOR DYSFUNCTION; MOUSE; NERVE CELL LESION; NERVE DEGENERATION; NONHUMAN; PARALYSIS; PATHOPHYSIOLOGY; TRANSGENE;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 0032079013     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09552.x     Document Type: Conference Paper

References (59)

1. GOETZL, E. J., D. C. ADELMAN & S. P. SREEDHARAN. 1990. Neuroimmunology. Adv. Immunol. 48:161-190.
2. PLATA-SALAMAN, C. R. 1991. Immunoregulators in the nervous system. Biobehav. Rev. 15:185-215.
3. MERRILL, J. E. & E. N. BENVENISTE. 1996. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci. 19:331-338.
4. MERRILL, J. E. 1992. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological. Dev. Neurosci. 14:1-10.
5. BENVENISTE, E. N. 1992. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am. J. Physiol. 263: C1-C16.
6. FREI, K., U. V. MAUPIERO, T. P. LEIST, R. M. ZINKERNAGEL, M. E. SCHWAB & A. FONTANA. 1989. On the cellular source and function of interleukin 6 produced in the central nervous system in viral disease. Eur. J. Immunol. 19:689-694.
7. GIUUAN, D., T. J. BAKER, L. N. SHIH & L. B. LACHMAN. 1986. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:594-604.
8. CHUNG, I. Y. & E. N. BENVENISTE. 1990. Tumor necrosis factor-α production by astrocytes. J. Immunol. 144:2999-3007.
9. LIEBERMAN, A. P., P. M. PITHA, H. S. SHIN & M. L. SHIN. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86: 6348-6352.
10. WAHL, S. M., J. B. ALLEN, N. MCCARTNEY-FRANCIS, M. C. MORGANTI-KOSSMANN, T. KOSSMANN, L. ELUNGSWORTH, U. E. H. MAI, S. E. MERGENHAGEN & J. M. ORENSTEIN. 1991. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in Acquired Immune Deficiency Syndrome. J. Exp. Med. 173:981-991.
11. DICKSON, D. W., S. C. LEE, L. A. MATTIACE & S.-H. C. YEN. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. GLIA 7: 75-83.
12. MERRILL, J. E. & I. Y. CHEN. 1991. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:2391-2396.
13. TYOR, W. R., J. D. GLASS, J. W. GRIFFIN, P. S. BECKER, J. C. MCARTHUR, L. BEZMAN & D. E. GRIFFIN. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:349-360.
14. EPSTEIN, L. G. & H. E. GENDELMAN. 1993. Human immunodeficiency virus type 1 infection of the nervous systenvpathogenetic mechanisms. Ann. Neurol. 33: 429-436.
15. GRIFFIN, W. S. T., L. C. STANLEY, C. LING, L. WHITE, V. MACLEOD, L. J. PERROT, C. L. WHITE III & C. ARAOZ. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86: 7611-7615.
16. BAUERJ., S. STRAUSS, U. SCHREITER-GASSER, U. GANTER, P. SCHLEGEL, I. Wnr, B. YOLK & M. BERGER. 1991. Interleukin-6 and a-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:111-114.
17. MERRILL, J. E. 1992. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunol. 12:167-170.
18. HOFMAN, F. M., D. R. HLMTON, K. JOHNSON & J. E. MERRILL. 1989. Tumor necrosis factor identified in multiple-sclerosis brain. J. Exp. Med. 170: 607-612.
19. CAMPBELL, I. L., M. EDDLESTON, P. KEMPER, M. B. A. OLDSTONE & M. V. HOBBS. 1994. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68: 2383-2387.
20. CAMPBELL, I. L., M. V. HOBBS, P. KEMPER & M. B. A. OLDSTONE. 1994. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 152: 716-723.
21. WAAGE, A., A. HALSTENSEN, R. SHALABY, P. BRANDTZ, P. KIERULF & T. ESPEVIK. 1989. Local production of tumor necrosis factor a, interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170:1859-1867.
22. CAMPBELL, I. L. 1995. Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci. 13:275-284.
23. CAMPBELL, I. L. & C.-S. CHIANG. 1995. Cytokine involvement in CNS disease:implications from transgenic mice. Ann. N. Y. Acad. Sci. 771:301-312.
24. CHIU, F.-C. & J. E. GOLDMAN. 1985. Regulation of glial fibrillary acidic protein (GFAP) expression in CNS development and in pathological states. J. Neuroimmunol. 8: 283-292.
25. HATTEN, M. E., R. K. H. LIEM, M. L. SHELANSKI & C. A. MASON. 1991. Astroglia in CNS injury. GLIA 4: 233-243.
26. BIGNAMI, A., D. DAHL & D. C. RUEGER. 1980. Glial fibrillary acidic protein (GFAP) in normal neural cells and in pathological conditions. Adv. Cell. Neurobiol. 1: 285-310.
27. EDDLESTON, M. & L. MUCKE. 1993. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 54:15-36.
28. MUCKE, L., M. B. A. OLDSTONE, J. C. MORRIS & M. I. NERENBERG. 1991. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 3: 465-474.
29. CAMPBELL, I. L., C. R. ABRAHAM, E. MASUAH, P. KEMPER, J. D. INGUS, M. B. A. OLDSTONE &L. MUCKE. 1993. Neurologic disease induced in transgenic mice by the cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90:10061-10065.
30. CHIANG, C.-S., H. C. POWELL, L. GOLD, A. SAMIMI & I. L. CAMPBELL. 1996. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest. 97:1512-1524.
31. STALDER, A. K., A. PAGENSTECHER & I. L. CAMPBELL. 1996. Lymphocytic meningoencephalomyelitis induced by the transgenic expression of TNF-α in the CNS. Soc. Neurosci. Abstr. 22:1455.
32. AKWA, Y., M. L. ELORANTA, K. SANDBERG, H. C. POWELL, F. E. BLOOM & I. L. CAMPBELL. 1996. Encephalopathy induced by the astrocyte-targeted expression of interferon-a in transgenic mice. Soc. Neurosci. Abstr. 22: 278.
33. AKIRA, S., T. HIRANO, T. TAGA & T. KISHIMOTO. 1990. Biology of multifunctional cytokines: IL6 and related molecules (IL 1 and TNF). FASEB J. 4: 2860-2867.
34. LE, J. & J. VlLCEK. 1989. Biology of disease-Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61: 588-602.
35. GALLO, P., K. FREI, C. RORDORF, J. LAZDINS, B. TAVOLATO & A. FONTANA. 1989. Human immunodeficiency virus type l (HIV-1) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23:109-116.
36. FREI, K., T. P. LEIST, A. MEAGER, P. GALLO D. LEPPERT, R. M. ZINKERNAGEL & A. FONTANA. 1988. Production of B-cell stimulatory factor-2 and Interferon y in the central nervous system during viral meningitis and encephalitis. J. Exp. Med. 168: 449-153.
37. HOUSSIAU, F. A., K. BUKASA, C. J. M. SINDIC, J. VAN DAMMES & J. VAN SNICK. 1988. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin. Exp. Immunol. 71: 320-323.
38. HOFMAN, R M-, D. R. HINTON, J. BAEMAYR, M. WEIL & J. E. MERRILL. 1991. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin. Immunol. Immunopathol. 58: 331-342.
39. WOODROOFE, M. N., G. S. SARNA, M. WADHWA, G. M. HAYES, A. J. LOUGHLIN, A. TINKER & M. L. CUZNER. 1991. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33:227-236.
40. BAZAN, J. F. 1991. Neuropoietic cytokines in the hematopoietic fold. Neuron 7:197-208.
41. PATTERSON, P. H. 1992. The emerging neuropoietic cytokine family: First CDF/LIF, CNTR and IL-6; next ONC, MGF, GCSF? Curr. Opin. Neurobiol. 2: 94-97.
42. GOLD, L. H., C. J. HEYSER & I. L. CAMPBELL. 1995. Progressive cognitive impairment in discriminated avoidance in GFAP-IL6 transgenic mice. Soc. Neurosci. Abstr. 21: 2110.
43. REICHLIN, S. 1993. Neuroendocrine-immune interactions. N. Engl. J. Med. 329: 1246-1253.
44. O'SiiEA, R., F. E. BLOOM, I. L. CAMPBELL & J. RABER. 1996. Central overexpression of interleukin-6 modulates hypothalamic-pituitary-adrenal (HPA) function. Soc. Neurosci. Abstr. 22:1354.
45. STEFFENSEN, S. C., I. L. CAMPBELL & S. J. HENRIKSEN. 1994. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652:149-153.
46. BELLINGER, F. P., S. G. MADAMBA, I. L. CAMPBELL & G. SIGGINS. 1995. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 198: 95-98.
47. BRETT, F. M., A. P. MIZISIN, H. C. POWELL & I. L. CAMPBELL. 1995. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 54: 766-775.
48. CHIANG, C.-S., A. STALDER, A. SAMIMI & I L. CAMPBELL. 1994. Reactive gliosis as a consequence of interleukin-6 expression in the brain. Studies in transgenic mice. Dev. Neurosci. 16: 212-221.
49. BARNUM, S. R., J. L. JONES, U. MULLER-LADNER, A. SAMIMI & I. L. CAMPBELL. 1996. Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 18:107-117.
50. CAMPBELL, I. L. 1994. Proliferative angiopathy in the brain induced by the cerebral overexpression of interleukin-6 in transgenic mice. J. Cell. Biochem. 18A: 283.
51. FRENDL, G. & D. I. BELLER. 1990. Regulation of macrophage activation by IL-3. J. Immunol. 144: 3392-3399.
52. FRENDL, G. 1992. Interleukin 3: From colony-stimulating factor to pluripotent immunoregulatory cytokine. J. Immunol. 14:421-430.
53. GEBICKE-HAERTER, P. J., K. APPEL, G. D. TAYLOR, A. SCHOBERT, I. N. RICH, H. NORTHOFF & M. BERGER. 1994. Rat microglial interleukin-3. J. Neuroimmunol. 50: 203-214.
54. APPEL, K., M. BUTTINI, A. SAUTER & P. J. GEBICKE-FIAERTER. 1995. Cloning of rat interleukin-3 β-subunit from cultured microglia and its RNA expression in vivo. J. Neurosci. 15:5800-5809.
55. LEE, T. T., F. C. MARTIN & J. E. MERRILL. 1993. Lymphokine induction of rat microglia multinucleated giant cell formation. GLIA 8:51-61.
56. QUAGUARELLO, V. & W. M. ScHELD. 1992. Bacterial meningitis: Pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327: 864-872.
57. ACHIM, C. L., M. P. HEYES & C. A. WILEY. 1993. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91: 2769-2775.
58. SELMAJ, K., C. S. RAINE, B. CANNELLA & C. F. BROSNAN. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87: 949-954.
59. Louis, J.-C, E. MAGAL, S. TAKAYAMA & S. VARON. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259: 689-692.